Nah, I doubt it. I mean, anything is possible I guess but if that were true we'd see insider buying happening and that requires its own filing with the SEC and we'd see that happening. And if that happened, we'd see the price rise because everyone would start drawing that same conclusion: "something big is happening so the insiders are buying up more for themselves!"
They're not really doing anything that's terribly unusual for any company, and not at ALL unusual for a small cap OTC company.
The merger- that will be done if and when it's done. Not before. Not on our timetable. There are no hard expiration dates on that one. The LOI was extended but that doesn't really mean anything. They can keep talking and negotiating for 6 months if they want to. Now I doubt they WANT to keep talking that long without moving forward but the point is: they can. And they're not under any obligation to release news or updates or complete any deal by any day.
The 10Q - yeah, they're late in filing. That sucks. They'll probably get a fine from the SEC for it. But 1,000 other companies are late on filing their 10Q and get fines. It's not super surprising nor is it unusual for any company, especially OTC.
Plenty of companies, even and especially small cap OTC companies, go months upon months without an news or PR or filings. This isn't unusual. It's frustrating for us, sure. But not unusual.
All signs point to good, if not great Q2 revenues. There's important things coming up in September and October even if the Ontario deal doesn't go through. And if the deal does go through, even better.
It's a process. Just gotta wait it out.
News 
Market Data 
Discover 
